• Login
    View Item 
    •   DSpace Home
    • School of Medicine
    • Journal Papers in Scopus 2
    • View Item
    •   DSpace Home
    • School of Medicine
    • Journal Papers in Scopus 2
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Cancers related to immunodeficiencies: Update and perspectives

    Thumbnail
    Date
    2016-09-20
    Author
    Esmaeil Mortaz
    Esmaeil Mortaz
    Esmaeil Mortaz
    Payam Tabarsi
    Davod Mansouri
    Adnan Khosravi
    Johan Garssen
    Johan Garssen
    Aliakbar Velayati
    Ian M. Adcock
    Metadata
    Show full item record
    Abstract
    © 2016 Mortaz, Tabarsi, Mansouri, Khosravi, Garssen, Velayati and Adcock. The life span of patients with primary and secondary immunodeficiency is increasing due to recent improvements in therapeutic strategies. While the incidence of primary immunodeficiencies (PIDs) is 1:10,000 births, that of secondary immunodeficiencies are more common and are associated with posttransplantation immune dysfunction, with immunosuppressive medication for human immunodeficiency virus or with human T-cell lymphotropic virus infection. After infection, malignancy is the most prevalent cause of death in both children and adults with (PIDs). PIDs more often associated with cancer include common variable immunodeficiency (CVID), Wiskott-Aldrich syndrome, ataxia-telangiectasia, and severe combined immunodeficiency. This suggests that a protective immune response against both infectious non-self-(pathogens) and malignant self-challenges (cancer) exists. The increased incidence of cancer has been attributed to defective elimination of altered or "transformed" cells and/or defective immunity towards cancer cells. The concept of aberrant immune surveillance occurring in PIDs is supported by evidence in mice and from patients undergoing immunosuppression after transplantation. Here, we discuss the importance of PID defects in the development of malignancies and the current limitations associated with molecular pathogenesis of these diseases and emphasize the need for further knowledge of how specific mutations can modulate the immune system to alter immunosurveillance and thereby play a key role in the etiology of malignancies in PID patients.
    DOI
    http://dx.doi.org/10.3389/fimmu.2016.00365
    Collections
    • Journal Papers in Scopus 2

    Contact Us | Send Feedback
     

     

    Browse

    All of DSpaceCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

    My Account

    LoginRegister

    Contact Us | Send Feedback